TB
TRex Bio
United States · Biotech
Develops precision immunoregulatory medicines based on tissue Treg biology
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed | $50M | Affinity Asset Advisors — Role not disclosedAlexandria Venture Investments — Role not disclosedAvego BioScience Capital — Role not disclosedBalyasny Asset Management — Role not disclosedDelos Capital — Role not disclosedEli Lilly and Company — Role not disclosedJanus Henderson Investors — Role not disclosedJohnson & Johnson Innovation – JJDC — Role not disclosedPfizer Ventures — Role not disclosedPolaris Partners — Role not disclosedSV Health Investors — Role not disclosed |